151 related articles for article (PubMed ID: 34351903)
1. Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
Tadesse D; Abdissa A; Mekonnen M; Belay T; Hailu A
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009632. PubMed ID: 34351903
[TBL] [Abstract][Full Text] [Related]
2. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines.
Babaloo Z; Kaye PM; Eslami MB
Trans R Soc Trop Med Hyg; 2001; 95(1):85-8. PubMed ID: 11280075
[TBL] [Abstract][Full Text] [Related]
5. Leishmania infantum-specific production of IFN-γ and IL-10 in stimulated blood from dogs with clinical leishmaniosis.
Solano-Gallego L; Montserrrat-Sangrà S; Ordeix L; Martínez-Orellana P
Parasit Vectors; 2016 Jun; 9(1):317. PubMed ID: 27260142
[TBL] [Abstract][Full Text] [Related]
6. Anti-Interleukin-10 Unleashes Transcriptional Response to Leishmanial Antigens in Visceral Leishmaniasis Patients.
Singh OP; Syn G; Nylén S; Engwerda C; Sacks D; Wilson ME; Kumar R; Chakravarty J; Sundar S; Blackwell JM; Fakiola M
J Infect Dis; 2021 Feb; 223(3):517-521. PubMed ID: 32614452
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in Northern Ethiopia.
Abbasi I; Aramin S; Hailu A; Shiferaw W; Kassahun A; Belay S; Jaffe C; Warburg A
BMC Infect Dis; 2013 Mar; 13():153. PubMed ID: 23530965
[TBL] [Abstract][Full Text] [Related]
10. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
[TBL] [Abstract][Full Text] [Related]
11. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
13. Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.
Elmekki MA; Elhassan MM; Ozbak HA; Mukhtar MM
Ann Saudi Med; 2016; 36(1):73-7. PubMed ID: 26922691
[TBL] [Abstract][Full Text] [Related]
14. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.
de Medeiros IM; Castelo A; Salomão R
Rev Inst Med Trop Sao Paulo; 1998; 40(1):31-4. PubMed ID: 9713135
[TBL] [Abstract][Full Text] [Related]
15. Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.
Sabur A; Bhowmick S; Chhajer R; Ejazi SA; Didwania N; Asad M; Bhattacharyya A; Sinha U; Ali N
Front Immunol; 2018; 9():18. PubMed ID: 29441060
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to
Ibarra-Meneses AV; Ghosh P; Hossain F; Chowdhury R; Mondal D; Alvar J; Moreno J; Carrillo E
Front Cell Infect Microbiol; 2017; 7():200. PubMed ID: 28620584
[TBL] [Abstract][Full Text] [Related]
17. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
18. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
19. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
20. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
